RIGL Rigel Pharmaceuticals posts Q4 2025 EPS below analyst estimates with shares slipping 11 in todays trading RDNW RideNow Group posts narrow Q4 2025 EPS miss amid operational headwinds shares remain unchanged Why are smart money investors paying attention to DaVita DVA Trend Strengthens 20260508 Why CenterPoint CNP is a smarter play than most realize Weakens 20260508